Measles outbreak with unique virus genotyping, Ontario, Canada, 2015

Emerging Infectious Diseases

Volumn 23, Issue 7, 2017, Pages 1063-1069

  Thomas, Shari ^a   Hiebert, Joanne ^b   Gubbay, Jonathan B ^a   Gournis, Effie ^c   Sharron, Jennifer ^d   Severini, Alberto ^b,f   Jiaravuthisan, Manisa ^e   Shane, Amanda ^b   Jaeger, Valerie ^d   Crowcroft, Natasha S ^a,c   Fediurek, Jill ^a   Sander, Beate ^a,c   Mazzulli, Tony ^a,c   Schulz, Helene ^f   Deeks, Shelley L ^a,c  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Niagara Region Public Health   (Canada)

^e TORONTO PUBLIC HEALTH   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ARTICLE; FEMALE; GENOTYPE; HUMAN; INTERVIEW; MALE; MEASLES VIRUS; NONHUMAN; ONTARIO; PUBLIC HEALTH; ADOLESCENT; ADULT; CHILD; CLASSIFICATION; DNA SEQUENCE; EPIDEMIC; GENETICS; HEALTH SURVEY; HISTORY; MEASLES; SEROTYPE; VACCINATION; VIROLOGY; YOUNG ADULT;

VIRUS RNA;

ADOLESCENT; ADULT; CHILD; DISEASE OUTBREAKS; FEMALE; GENOTYPE; HISTORY, 21ST CENTURY; HUMANS; MALE; MEASLES; MEASLES VIRUS; ONTARIO; PUBLIC HEALTH SURVEILLANCE; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEROGROUP; VACCINATION; YOUNG ADULT;

EID: 85021082631     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2307.161145     Document Type: Article

References (22)

1. World Health Organization. Final report of the XIX Technical Advisory Group (TAG) meeting on vaccine-preventable diseases of the Pan American Health Organization—Buenos Aires, Argentina, 6–8 July 2011 [cited 2016 May 25]. http://www.who.int/immunization/sage/5_PAHO-TAG2011_nov11.pdf
2. Public Health Agency Of Canada. Elimination of measles, rubella and congenital rubella syndrome in Canada: documentation and verification report [cited 2016 May 25]. http://www.phac-aspc. gc.ca/im/vpd-mev/measles-rougeole-mrer-eng.php
3. Pan American Health Organization. Plan of action documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the Region of the Americas [cited 2016 May 25]. http://www.paho.org/hq/index.php?option=com_docman&task=doc_download&gid=16739&Itemid=270
4. Ontario Agency for Health Protection and Promotion (Public Health Ontario). Immunization coverage report for school pupils: 2012–13 school year. Toronto: Queen’s printer for Ontario; 2014 [cited 2016 May 25]. https://www.publichealthontario.ca/en/eRepository/Immunization_coverage_report_2012-13.pdf
5. van Boven M, Kretzschmar M, Wallinga J, O’Neill PD, Wichmann O, Hahné S. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface. 2010;7:1537–44. http://dx.doi.org/10.1098/rsif.2010.0086
6. Anderson RM, May RM. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond). 1983;90:259–325. http://dx.doi.org/10.1017/S002217240002893X
7. Ontario Ministry of Health and Long-term Care. Infectious diseases protocol appendix A [cited 2015 Dec 7]. http://www.health.gov.on.ca/en/pro/programs/publichealth/oph_standards/docs/measles_chapter.pdf
8. Ontario Ministry of Health and Long-term Care. Infectious diseases protocol appendix B [cited 2015 Dec 7]. http://www.health.gov.on.ca/en/pro/programs/publichealth/oph_standards/docs/measles_cd.pdf
9. Hummel KB, Lowe L, Bellini WJ, Rota PA. Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens. J Virol Methods. 2006;132:166–73. http://dx.doi.org/10.1016/j.jviromet.2005.10.006
10. World Health Organization. Measles virus nomenclature update: 2012. Wkly Epidemiol Rec. 2012;87:73–81.
11. Kessler JR, Kremer JR, Shulga SV, Tikhonova NT, Santibanez S, Mankertz A, et al. Revealing new measles virus transmission routes by use of sequence analysis of phosphoprotein and hemagglutinin genes. J Clin Microbiol. 2011;49:677–83. http://dx.doi.org/10.1128/JCM.01703-10
12. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30:2725–9. http://dx.doi.org/10.1093/molbev/mst197
13. Heymann D. Control of communicable diseases manual, 20th edition. Washington: American Public Health Association; 2015. p. 392.
14. Batagelj V, Mrvar A. Pajek—program for large network analysis. Connections. 1998;21:47–57.
15. Gournis E, Shane A, Shane E, Arthur A, Berger L. Exploring gaps in surveillance of a small measles outbreak in Toronto. Can Commun Dis Rep. 2016;42:146–8.
16. Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller CP, et al. Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis. 2011;204 (Suppl 1):S514–23. http://dx.doi.org/10.1093/infdis/jir118
17. Wilson SE, Khan K, Gilca V, Miniota J, Deeks SL, Lim G, et al. Global travel patterns and risk of measles in Ontario and Quebec, Canada: 2007-2011. BMC Infect Dis. 2015;15:341. http://dx.doi.org/10.1186/s12879-015-1039-0
18. King A, Varughese P, De Serres G, Tipples GA, Waters J; Working Group on Measles Elimination. Measles elimination in Canada. J Infect Dis. 2004;189(Suppl 1):S236–42. http://dx.doi.org/10.1086/378499
19. Ontario Agency for Health Protection and Promotion (Public Health Ontario). Measles in Ontario: update for clinicians [cited 2016 Feb 17]. https://www.publichealthontario.ca/en/eRepository/Measles_Update_for_Clinicians.pdf
20. Dietz V, Rota J, Izurieta H, Carrasco P, Bellini W. The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas. Bull World Health Organ. 2004;82:852–7.
21. Shane A, Hiebert J, Sherrard L, Deehan H. Measles surveillance in Canada: trends for 2013. Can Commun Dis Rep. 2014;40:219–32.
22. Hiebert J, Severini A. Measles molecular epidemiology: what does it tell us and why is it important? Can Commun Dis Rep. 2014;40:257.